Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database-Reference-Cited by-同舟云学术

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database

Published:2018-11 Issue: Volume:103 Page:205-213
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Salem Mohamed E.,Yin Jun,Weinberg Benjamin A.,Renfro Lindsay A.,Pederson Levi D.,Maughan Timothy S.,Adams Richard A.,Van Cutsem Eric,Falcone Alfredo,Tebbutt Niall C.,Seymour Matthew T.,Díaz-Rubio Eduardo,Aranda Enrique,Bokemeyer Carsten,Heinemann Volker,Wasan Harpreet,de Gramont Aimery,Grothey Axel,Shi Qian,Sargent Daniel J.,Marshall John L.

Funder

ARCAD

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Colorectal cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Cancer facts & figures;American Cancer Society,2017

3. Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial;Venook;JAMA,2017

4. Impact of primary tumor location on overall survival and progression-free survival in patients with metastatic colorectal cancer: analysis of CALGB/SWOG 80405 (Alliance);Venook;J Clin Oncol,2016

5. Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials;Tejpar;JAMA Oncol,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Test for Realized Missingness in Mixed-type Data;Sankhya B;2023-12-20

2. Procyanidin C1 inhibits tumor growth and metastasis in colon cancer via modulating miR-501-3p/HIGD1A axis;Journal of Advanced Research;2023-07

3. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer;JAMA Network Open;2023-01-19

4. Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years;European Journal of Cancer;2022-03

5. Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer;Frontiers in Oncology;2022-01-07